搜索结果31-40 的 854 / anti-TNF drugs

  1. 神经科- 临床试验- 妙佑医疗国际

    To describe the clinical features along with treatment outcomes of a cohort of patients with a diagnosis of NMOSD after the latest revised criteria in 2015 by ...

  2. 普通内科- 临床试验- 妙佑医疗国际

    ... drugs, which selectively eliminate senescent cells, should be initiated. ... The third aim is to measure SARS-CoV-2 anti-spike and anti ... drugs, which selectively ...

  3. 神经科- 临床试验- 妙佑医疗国际

    ... Therapy. Rochester, Minn. The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as ...

  4. 消费者健康Medications - 妙佑医疗国际

    对自身健康负责。了解有哪些方案适合您。明智地选用药物和补充剂。要清楚地了解自身情况，并向医疗护理专业人员咨询相关问题。

  5. 神经科- 临床试验- 妙佑医疗国际

    ... Therapy. Rochester, Minn. The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as ...

  6. 神经科- 临床试验- 妙佑医疗国际

    To describe the clinical features along with treatment outcomes of a cohort of patients with a diagnosis of NMOSD after the latest revised criteria in 2015 by ...

  7. 临床试验- 明尼苏达州的儿童血液/肿瘤科- 妙佑医疗国际儿童中心

    ... therapy that may cause loss of reproductive potential. A Study to Develop Liquid Biopsy for Pediatric Brain Tumor Patients. Rochester, Minn. The purpose of ...

  8. 肺癌计划- 临床试验- 妙佑医疗国际

    ... anti-PD(L)1 antibodies) treatment, CPI-naïve hepatocellular carcinoma (HCC), and treatment-naïve endometrioid endometrial cancer. A Study to Evaluate the ...

  9. Mayo Clinic Neurosciences Physician Update — July 2024

    Page 1.

  10. 神经科- 临床试验- 妙佑医疗国际

    To describe the clinical features along with treatment outcomes of a cohort of patients with a diagnosis of NMOSD after the latest revised criteria in 2015 by ...